|
Based on Lipocine's core competencies in drug absorption, lipid metabolism, surface and colloid chemistry, proteins/peptides, and physicochemical characterization, Lipocine technologies utilize lipidic multiphase systems to meet varied range of unmet therapeutic needs and market opportunities.
| | POORLY WATER SOLUBLE DRUGS
• Lip'ral : Clinically proven delivery technology for enhanced bioavailability of insoluble drugs.
• Lip'ral-SSR (Synchronized Solubilizer Release) : Breakthrough controlled release technology for insoluble drugs.
• Nanosplode: Solid lipid dispersions supporting a wide range of dosage form designs
| POORLY PERMEABLE DRUGS
• Hydroance : Novel delivery technology for water soluble, poorly permeable drugs, especially macromolecules.
• Nanosplode: Solid lipid dispersions supporting a wide range of dosage form designs |
|
PARENTERAL
• Li'IV: For patient friendly parenteral delivery |
TRANSMUCOSAL
• Mistocine: For superior intranasal or buccal delivery |
In addition to the available proprietary technologies, Lipocine offers LipidScreen® to quickly and cost effectively screen challenging compounds and to provide our clients with formulation strategies to overcome the issues presented with poorly water soluble and poorly permeable molecules. |
Technologies 
